ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 701759 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 701759; 2) Community: the network communities that were significantly associated with the response to NSC 701759; 3) Molecule: the relationships between components within communities and NSC 701759; 4) MDR: the compounds that were significantly associated with the NSC 701759.

NSC Compound Enrichment Correlation
NSC 674278 Null 0.0119653763676522 -0.29574423
NSC 681684 2-Trifluoroethoxy-6-oxoestra-1,3,5(10)-trien-3,17.beta.-diol 0.0119653763676522 0.51212329
NSC 685034 Null 0.0119653763676522 0.1123178
NSC 691894 Null 0.0119653763676522 0.29302858
NSC 146268 as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- 0.0133986477026051 0.44163637
NSC 178248 Chlorozotocin 0.0133986477026051 0.1980651
NSC 252628 1H-Purine, 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)seleno]- 0.0133986477026051 0.02345299
NSC 295499 Camptothecin Derivative 0.0133986477026051 0.24344711
NSC 337851 Pregna-1,4-diene-3,11,20-trione, 21-[[[[3,6-bis(dimethylamino)-9-acridinyl]thio]acetyl]oxy]-17-hydroxy- 0.0133986477026051 0.39727497
NSC 354051 LISCUNDITRIN 0.0133986477026051 0.15058437
Total:51  Current:14    [First] [Prev] [Next] [Last]